nivolumab
bms
['nivo', 'cm-816']
dr. presents qol data from ph3 cm-816 trial at #esmo22. no diff in change of hrqol observed with addition of nivo to chemo, further supporting tolerability of this approach. 
Thoracic Medical Oncologist @lombardicancer, Assistant Professor @Georgetown. Interested in immunotherapy translational clinical trials. Opinions are my own.